Location: Boston, MA
CIK: 0001732811 · Show all filings
Period: Q3 2019 (← Previous) (Next →)
Filing Date: Nov 14, 2019
Total Value: $669M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ALLERGAN PLC | 1,400,101 | $236M | 35.2% | $152.06 | — | SHS | G0177J108 |
| FOXA | FOX CORP | 2,369,331 | $74.72M | 11.2% | $35.41 | -10.3% | CL A COM | 35137L105 |
| — | LIBERTY GLOBAL PLC | 3,000,000 | $71.37M | 10.7% | $24.36 | — | SHS CL C | G5480U120 |
| LNG | CHENIERE ENERGY INC | 1,050,000 | $66.21M | 9.9% | $62.26 | +2.9% | COM NEW | 16411R208 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 6,439,541 | $55.28M | 8.3% | $11.07 | -12.2% | COM CL A | 46333X108 |
| XPO | XPO LOGISTICS INC | 700,000 | $50.1M | 7.5% | $27.03 | -14.4% | COM | 983793100 |
| — | PIONEER NAT RES CO | 263,500 | $33.14M | 5.0% | $130.13 | — | COM | 723787107 |
| PCG | PG&E CORP | 2,800,000 | $28M | 4.2% | $21.11 | -29.2% | COM | 69331C108 |
| — | FGL HLDGS | 2,896,186 | $23.11M | 3.5% | $7.72 | — | ORD SHS | G3402M102 |
| — | CYCLERION THERAPEUTICS INC | 1,487,874 | $18.03M | 2.7% | $11.45 | — | COM | 23255M105 |
| — | GTT COMMUNICATIONS INC | 981,143 | $9.242M | 1.4% | $22.45 | — | COM | 362393100 |
| EOLS | EVOLUS INC | 120,000 | $1.874M | 0.3% | $19.82 | -17.3% | COM | 30052C107 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,500,000 | $1.62M | 0.2% | $10.31 | -86.2% | COM | 00461U105 |
| — | REVANCE THERAPEUTICS INC | 46,000 | $598K | 0.1% | $20.13 | — | COM | 761330109 |